A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron in vivo.
Zuo D, Chen Y, Cai JP, Yuan HY, Wu JQ, Yin Y, Xie JW, Lin JM, Luo J, Feng Y, Ge LJ, Zhou J, Quinn RJ, Zhao SJ, Tong X, Jin DY, Yuan S, Dai SX, Xu M.
Zuo D, et al. Among authors: feng y.
Protein Cell. 2022 Jul 15;14(1):37-50. doi: 10.1093/procel/pwac027. eCollection 2023 Jan.
Protein Cell. 2022.
PMID: 36726760
Free PMC article.